Synovial Sarcoma Survival


Our synovial sarcoma nomogram is a tool designed to predict the likelihood of surviving three years and five years after being diagnosed with synovial sarcoma, based on clinical and pathologic factors known before surgery. This tool is not designed for patients who received chemotherapy with anthracycline and ifosfamide (AI) before or shortly after surgery, as the nomogram predictions may be inaccurate.

Results produced by this tool are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of synovial sarcoma procedures. All results must be understood in the context of each patient’s specific treatment plan. Patients and caregivers using this tool should discuss the result with the patient’s physician.

To gather the information required to use this nomogram, use our worksheet.

Enter Your Information

All fields are required unless noted optional
Note: A tumor is considered to be in the upper extremity if it is in the hand, arm, or shoulder joint, and it is considered to be in the lower extremity if it is in the foot, leg, or groin.
cm (1 to 30)
Note: The depth of the tumor is categorized as either superficial or deep relative to the investing fascia. Depth is considered deep if it involves the superficial fascia or involves underlying muscle.
What is fascia?
Fascia refers to a sheet of connective tissue surrounding and binding together body structures, such as muscles, blood vessels, and nerves. The superficial fascia lies under the skin and superficial fat layers, and it surrounds and binds together the underlying muscles.
What is histology?
Histology refers to the exact type of cancer based on examination of the tumor tissue under the microscope. Synovial sarcoma is classified as Biphasic; Monophasic; or Poorly Differentiated.